Signaturefd, LLC Krystal Biotech, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 130 shares of KRYS stock, worth $25,547. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130

Previous 133 2.26%

Holding current value

$25,547

Previous $24,000 4.17%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$174.7 - $213.66 $524 - $640	-3 Reduced 2.26%	130 $23,000
Q2 2024 Jul 29, 2024	BUY	$153.12 - $183.64 $5,052 - $6,060	33 Added 33.0%	133 $24,000
Q1 2024 May 03, 2024	BUY	$108.01 - $179.35 $324 - $538	3 Added 3.09%	100 $17,000
Q4 2023 Jan 31, 2024	SELL	$96.0 - $128.29 $4,512 - $6,029	-47 Reduced 32.64%	97 $12,000
Q3 2023 Nov 03, 2023	BUY	$108.51 - $130.22 $1,953 - $2,343	18 Added 14.29%	144 $16,000
Q2 2023 Aug 01, 2023	SELL	$78.48 - $130.32 $1,255 - $2,085	-16 Reduced 11.27%	126 $14,000
Q1 2023 Apr 28, 2023	SELL	$72.39 - $84.27 $2,316 - $2,696	-32 Reduced 18.39%	142 $11,000
Q4 2022 Jan 27, 2023	BUY	$63.14 - $79.9 $4,040 - $5,113	64 Added 58.18%	174 $13,000
Q3 2022 Nov 08, 2022	BUY	$64.85 - $82.4 $518 - $659	8 Added 7.84%	110 $8,000
Q2 2022 Aug 10, 2022	BUY	$48.93 - $73.47 $440 - $661	9 Added 9.68%	102 $7,000
Q1 2022 May 02, 2022	SELL	$51.99 - $72.11 $6,498 - $9,013	-125 Reduced 57.34%	93 $6,000
Q4 2021 Jan 25, 2022	BUY	$39.81 - $88.24 $8,678 - $19,236	218 New	218 $15,000
Q2 2021 Jul 26, 2021	SELL	$62.14 - $81.82 $3,293 - $4,336	-53 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$59.42 - $85.46 $3,149 - $4,529	53 New	53 $4,000
Q3 2020 Nov 03, 2020	SELL	$37.76 - $48.49 $1,472 - $1,891	-39 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$35.02 - $65.64 $1,365 - $2,559	39 New	39 $2,000

Others Institutions Holding KRYS

# of Institutions

311

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.04B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account